{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-018997","form_type":"8-K","ticker":"APRE","cik":"0001781983","company_name":"Aprea Therapeutics, Inc.","filed_at":"2023-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.517449+00:00","generated_at":"2026-06-19T16:23:17.227100+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aprea Therapeutics completes 1-for-20 reverse stock split to regain Nasdaq compliance","bullets":["Reverse stock split effective 5:00 pm ET on Feb 10, 2023; stock trades split-adjusted from Feb 13, 2023 under symbol APRE.","Outstanding shares reduced from ~53,631,405 to ~2,681,570; authorized shares and par value unchanged.","New CUSIP number 03836J201; fractional shares aggregated and sold, with cash payments to holders.","Split intended to increase per-share price to meet Nasdaq continued listing requirements.","Proportionate adjustments made to equity awards, option exercise prices, and shares available under plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-018997","json":"https://secwatch.observer/filing/0001104659-23-018997.json","markdown":"https://secwatch.observer/filing/0001104659-23-018997.md","text":"https://secwatch.observer/filing/0001104659-23-018997.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781983/000110465923018997/0001104659-23-018997-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781983/000110465923018997/tm236225d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T16:23:17.227100+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"746fe1cd690f9896ee1f7315e2a62596a8590036","claim":"Aprea Therapeutics, Inc.: Amended Certificate of Incorporation to effect a one-for-20 reverse stock split (effective 2023-02-10).","evidence_excerpt":"the Company filed an amendment to its Certificate of Incorporation (the ‘Amendment”) with the Secretary of State of the State of Delaware to effect the Reverse Stock Split, with an effective time of 5:00 p.m. on February 10, 2023.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1781983/000110465923018997/0001104659-23-018997-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-02-10"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}